Apellis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Apellis Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Apellis Pharmaceuticals Inc
Rating: 2.58175
Author: Trendlyne DVM scores

Turnaround Potential

about

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

41.03 -0.03 (-0.07%)

Near 52W High of $41.14

68.6M

XNAS Volume

High volume today

XNAS 13 May, 2026 5:30 PM (EDT)

Board Meeting

The board meeting for Apellis Pharma Inc is scheduled for today, for the purpose of Apellis Pharmaceuticals Inc First Quarter Earnings Conference Call for 2026 See details

Medium Financial Strength

50.0 / 100

Mid Valuation

37.5 / 100

Technically Moderately Bullish

69.0 / 100

Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM

1Yr Price target downside is 0%

15 analysts

Apellis Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Apellis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

Near 52W High of $41.14

High volume today

SWOT Analysis

Apellis Pharma Inc Live Price Chart